In this episode, lung cancer experts discuss the treatment approach for patients with early-stage, resectable NSCLC who harbor EGFR sensitizing mutations. Listen to the latest clinical trial data on the use of adjuvant targeted therapy for this patient population.
In this episode, lung cancer experts discuss the treatment approach for patients with early-stage, resectable NSCLC who harbor EGFR sensitizing mutations. Listen to the latest clinical trial data on the use of adjuvant targeted therapy for this patient population.